Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon NyrtfiledCriticalRichter Gedeon Nyrt
Priority to DO2007000086ApriorityCriticalpatent/DOP2007000086A/en
Publication of DOP2007000086ApublicationCriticalpatent/DOP2007000086A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a los nuevos compuestos de fórmula (I) y a sus enantiómeros y/o racematos y/o diastereómeros y/o sales farmacéuticamente aceptables de los mismos formadas con ácidos o bases, a procesos para su preparación, a los intermedios de dichos procesos de preparación, a formulaciones farmacéuticas que contienen estos compuestos y a su utilización en la prevención y/o el tratamiento de trastornos mediados por el receptor mGluR5.The present invention relates to the new compounds of formula (I) and their enantiomers and / or racemates and / or pharmaceutically acceptable diastereomers and / or salts thereof formed with acids or bases, to processes for their preparation, to intermediates of said preparation processes, pharmaceutical formulations containing these compounds and their use in the prevention and / or treatment of disorders mediated by the mGluR5 receptor.
DO2007000086A2007-05-012007-05-01
NEW DERIVATIVES OF QUINOLINAS
DOP2007000086A
(en)
SUBSTITUTED DERIVATIVES OF N4- (5-METHYL-1H-PIRAZOL-3-IL) - 1,3,5-TRIAZINA-2,4-DIAMINE, THEIR ENANTIOMERS, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS, PREPARATION PROCESSES AND APPLICATIONS
DERIVED FROM THE 1, 3, 5-TRIAZINA-2, 4-DIAMINAS-6-SUBSTITUTED-N-SUBSTITUTED AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS AND APPLICATIONS.
Compounds derived from fumarate; pharmaceutical composition comprising them; and its use in the treatment of an inflammatory or neurodegenerative disease.
DERIVATIVES OF N-CICLOALQUIL-3-PHENYLNICOTINAMIDE INHIBITING PGDS, ITS COMPOSITIONS, ITS USE FOR THE TREATMENT FOR EXAMPLE OF ALLERGIC AND RESPIRATORY AFFECTIONS.
DERIVATIVES OF 2- (PIRIDIN-4-IL) PIRIDINE OR SALTS OF THE SAME AS MODULATORS OF PROTEIN QUINASA CDK9 AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
FORMS OF POLYMORPHES OF THE (2S) - (4E) -N-METHYL-5- (3-ISOPROPOXIPIRIDIN) IL] -4-PENTEN-2-AMINA FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
Substituted derivatives of 5-Halo-N2- [substituted] (1-methyl-1H-imidazol-4-yl) pyrimidin-2, -diamine and its pharmaceutically acceptable salts, preparation processes, compositions and applications.